🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate whether PF-02545920 reduces the effects of ketamine on brain ac...
Status
Terminated
Location
Pfizer Investigational Site
Start Date
2011-04
Trial ID
NCT01244880
Treatments Being Tested
The primary objective is to determine if the opioid properties of ketamine ...
Status
Completed
Location
Stanford University
Start Date
2016-09
Trial ID
NCT02911597
Treatments Being Tested
Prenatal depression is an important risk factor of postpartum depression. L...
Status
Completed
Location
Peking University First Hospital
Start Date
2020-06-19
Trial ID
NCT03927378
Treatments Being Tested
Background: Major depressive disorder (MDD) is a serious mental illness th...
Status
Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2024-11-06
Trial ID
NCT06511908
Treatments Being Tested
Sedation and analgesia in patients with sepsis and hemodynamic instability ...
Status
Unknown
Location
Southern medical university Nanfang hospital
Start Date
2023-05-31
Trial ID
NCT05839366
Treatments Being Tested
This study is a biomarker study designed to characterize how ketamine impac...
Status
Completed
Location
Stanford Psychiatry
Start Date
2019-08-19
Trial ID
NCT03475277
Treatments Being Tested
Prospective randomized double blinded, placebo controlled study that will e...
Status
Completed
Location
Dartmouth-Hitchcock
Start Date
2020-09-14
Trial ID
NCT04437888
Treatments Being Tested
Prospective feasibility trial utilizing adjuvant magnesium sulfate for anal...
Status
Not Yet Recruiting
Location
Hennepin County Medical Center
Start Date
2026-01-01
Trial ID
NCT07126795
Treatments Being Tested
The purpose of this research is to determine if scheduled intranasal ketami...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-01-01
Trial ID
NCT05671913
To explore and compare the effects of esketamine and remimazolam on postope...
Status
Completed
Location
Tianjin Medical University General Hospital
Start Date
2024-03-04
Trial ID
NCT06284668
Treatments Being Tested